Table 4:
Dexamethasone treatment for patients admitted with SDH
| Conservative management without dexamethasone (N=1907) | Conservative management with dexamethasone (N=148) | p-value | Surgery without adjuvant dexamethasone (N=1648) | Adjuvant Dexamethasone (N=212) | p-value | |
|---|---|---|---|---|---|---|
| Age in years, median (IQR) | 77 (65, 85) | 72 (60, 80) | 0.0002 | 72 (63, 81) | 69 (60, 78) | 0.004 |
| Race, N (%) | ||||||
| White | 1300 (68.2) | 110 (74.3) | 1076 (65.4) | 138 (65.1) | ||
| Black | 271 (14.2) | 16 (10.8) | 0.29 | 227 (13.8) | 26 (12.3) | 0.74 |
| Other | 334 (17.5) | 22 (14.9) | 342 (20.8) | 48 (22.6) | ||
| Unknown | 2 (0.1) | 0 | 3 (0.2) | 0 | ||
| Sex, N (%) | ||||||
| Female | 829 (43.5) | 53 (35.8) | 0.07 | 482 (29.2) | 69 (32.6) | 0.32 |
| Male | 1078 (56.5) | 95 (64.2) | 1166 (70.8) | 143 (67.4) | ||
| Care setting, N (%) | ||||||
| Nonacademic | 849 (44.5) | 56 (37.8) | 0.11 | 683 (41.4) | 97 (45.8) | 0.23 |
| Academic | 1058 (55.5) | 92 (62.2) | 965 (58.6) | 115 (54.2) | ||
| Region of United States, N (%) | ||||||
| Midwest | 375 (19.7) | 30 (20.3) | 294 (17.8) | 30 (14.2) | ||
| Northeast | 340 (17.8) | 22 (14.9) | 0.18 | 265 (16.1) | 32 (15.1) | 0.13 |
| South | 986 (51.7) | 87 (58.8) | 844 (51.2) | 126 (59.4) | ||
| West | 201 (10.8) | 9 (6.1) | 245 (14.9) | 24 (11.3) | ||